HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
MRK
Merck & Co Inc
Healthcare Drug Manufacturers - General · New Jersey, USA · Reports in usd
Market Cap: $278.38B
Market Cap
$278.38B
Enterprise Val
$313.16B
P/E Ratio
15.25
P/B Ratio
5.29
Trailing PEG (1Y)
-0.84
As Of
Apr 30, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$52.66B
Gross Margin66.15%
Profit Margin66.15%
Return on Equity36.19%
Return on Assets14.63%
Current Ratio1.54
Debt/Equity0.94
LT Debt/Equity0.89
Revenue Per Share6.61

Income Statement

Dec 31, 2025
Revenue$16.40B
Cost of Revenue$5.55B
Gross Profit$10.85B
R&D$3.89B
SG&A$2.90B
Operating Expenses$7.00B
Operating Income$3.85B
Interest Expense$411.0M
Tax Expense$458.0M
Net Income$2.96B
EPS (Basic)$1.21
EPS (Diluted)$1.20
EBIT$3.83B
EBITDA$6.30B
Consolidated Income$2.96B
Non-Controlling Interests-$1.0M

Balance Sheet

Dec 31, 2025
Cash & Equivalents$14.57B
Accounts Receivable$11.78B
Inventory$6.66B
Current Assets$43.52B
LT Investments$956.0M
Property, Plant & Equipment$25.32B
Intangibles$48.26B
Non-Current Assets$93.35B
Total Assets$136.87B
Accounts Payable$4.40B
Current Debt$2.59B
Current Liabilities$28.33B
LT Debt$46.75B
Non-Current Liabilities$55.88B
Total Liabilities$84.20B
Total Debt$49.34B
Retained Earnings$73.08B
Shareholder Equity$52.61B
Shares Outstanding2,482,022,536

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$2.86B
Investing Cash Flow-$11.20B
Financing Cash Flow$4.75B
CapEx-$1.03B
Free Cash Flow$1.82B
Depreciation & Amort.$2.47B
Stock-Based Comp$205.0M
Acquisitions / Disposals-$10.04B
Investment Activity$46.0M
Debt Issued/Repaid$7.85B
Equity Issued/Repaid-$1.21B
Dividends Paid-$2.02B
Net Change in Cash-$3.57B
Data cached · Meta live · Daily live · Statements live · TTL 24h